EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Mitigating off‐target effects of small RNAs: conventional approaches, network theory and artificial intelligence

Zoltán Bereczki, Bettina Benczik, Olivér M Balogh, Szandra Marton, Eszter Puhl, Mátyás Pétervári, Máté Váczy-Földi, Zsolt Tamás Papp, András Makkos, Kimberly Glass, Fabian Locquet, Gerhild Euler und 3 weitere

British Journal of Pharmacology · 2025-01 · 182 (2) · 340-379

DOI: 10.1111/bph.17302 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, online erschienen am 18.09.2024. Verfasst von Zoltán Bereczki und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Artificial Intelligence. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 332 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HUN-REN Hungarian Research Network, Ministry for Innovation and Technology in Hungary, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Three types of highly promising small RNA therapeutics, namely, small interfering RNAs (siRNAs), microRNAs (miRNAs) and the RNA subtype of antisense oligonucleotides (ASOs), offer advantages over small‐molecule drugs. These small RNAs can target any gene product, opening up new avenues of effective and safe therapeutic approaches for a wide range of diseases. In preclinical research, synthetic small RNAs play an essential role in the investigation of physiological and pathological pathways as silencers of specific genes, facilitating discovery and validation of drug targets in different conditions. Off‐target effects of small RNAs, however, could make it difficult to interpret experimental results in the preclinical phase and may contribute to adverse events of small RNA therapeutics. Out of the two major types of off‐target effects we focused on the hybridization‐dependent, especially on the miRNA‐like off‐target effects. Our main aim was to discuss several approaches, including sequence design, chemical modifications and target prediction, to reduce hybridization‐dependent off‐target effects that should be considered even at the early development phase of small RNA therapy. Because there is no standard way of predicting hybridization‐dependent off‐target effects, this review provides an overview of all major state‐of‐the‐art computational methods and proposes new approaches, such as the possible inclusion of network theory and artificial intelligence (AI) in the prediction workflows. Case studies and a concise survey of experimental methods for validating in silico predictions are also presented. These methods could contribute to interpret experimental results, to minimize off‐target effects and hopefully to avoid off‐target‐related adverse events of small RNA therapeutics. LINKED ARTICLES This article is part of a themed issue Non‐coding RNA Therapeutics. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.2/issuetoc

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceHumansAnimalsMicroRNAsRNA, Small InterferingOligonucleotides, Antisense

Stichwörter der Autor:innen

bioinformaticsceRNA networkchemical modificationsfunctional analysismachine learningneural networkpost‐transcriptional regulationrisk minimizationtarget identification

Substanzen

MicroRNAsRNA, Small InterferingOligonucleotides, Antisense

Autor:innen und Institutionen

  • Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
  • Center for Pharmacology and Drug Research & Development, Semmelweis University, Budapest, Hungary.
  • HUN-REN-SU System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
  • Pharmahungary Group, Szeged, Hungary.
  • Sanovigado Kft, Budapest, Hungary.
  • Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

ORCID-Profile: Bence Ágg

Förderung

  • HUN-REN Hungarian Research Network
  • Ministry for Innovation and Technology in Hungary
  • European Commission
  • Nemzeti Kutatási, Fejlesztési és Innovációs Alap
  • National Research, Development and Innovation Office of Hungary
  • Semmelweis 250+ Excellence Fellowship
  • New National Excellence Program of the Ministry for Culture and Innovation
  • National Heart, Lung and Blood Institute

Zitieren

APA

Bereczki, Z., Benczik, B., Balogh, O. M., Marton, S., Puhl, E., Pétervári, M., Váczy-Földi, M., Papp, Z. T., Makkos, A., Glass, K., Locquet, F., Euler, G., Schulz, R., Ferdinandy, P., & Ágg, B. (2025). Mitigating off‐target effects of small RNAs: conventional approaches, network theory and artificial intelligence. British Journal of Pharmacology, 182(2), 340-379. https://doi.org/10.1111/bph.17302

Vancouver

Bereczki Z, Benczik B, Balogh OM, Marton S, Puhl E, Pétervári M, et al. Mitigating off‐target effects of small RNAs: conventional approaches, network theory and artificial intelligence. British Journal of Pharmacology. 2025;182(2):340-379. doi:10.1111/bph.17302

BibTeX
@article{Bereczki2025,
  author = {Bereczki, Zoltán and Benczik, Bettina and Balogh, Olivér M and Marton, Szandra and Puhl, Eszter and Pétervári, Mátyás and Váczy-Földi, Máté and Papp, Zsolt Tamás and Makkos, András and Glass, Kimberly and Locquet, Fabian and Euler, Gerhild and Schulz, Rainer and Ferdinandy, Péter and Ágg, Bence},
  title = {Mitigating off‐target effects of small RNAs: conventional approaches, network theory and artificial intelligence},
  journal = {British Journal of Pharmacology},
  year = {2025},
  volume = {182},
  number = {2},
  pages = {340--379},
  doi = {10.1111/bph.17302}
}
Kostenlos starten →